| 5 | 1/1 | 返回列表 |
| 查看: 1231 | 回復(fù): 3 | |||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進(jìn)行查看 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | |||
xiaotongxyz木蟲 (正式寫手)
|
[交流]
求助翻譯中文摘要一份,重賞金幣,翻譯的好可追加
|
||
|
原文: 國產(chǎn)利培酮治療腦血管病所致精神障礙療效分析 摘要:目的:探討國產(chǎn)利培酮(思利舒)治療腦血管病所致精神障礙療效和安全性。方法:隨機抽取腦血管病所致精神障礙30例,用思利舒治療,并分別于治療前及治療后第1、2、4、8周末才去簡明精神病量表(BPRS)、陽性癥狀陰性癥狀量表(PANSS)及副作用量表(TCSS)評定臨床療效及不良反應(yīng)。結(jié)果:BPRS總分、PANSS總分和各癥狀評分均較治療前顯著降低,且有顯著差異(P<0.01~0.05),有效率:90%,顯效率:63%,常見不良反應(yīng)是體重增加、靜坐不能。結(jié)論:思利舒對腦血管所知精神障礙安全有效,不良反應(yīng)少,經(jīng)濟(jì)適用,值得臨床推廣使用。 |

木蟲 (正式寫手)

木蟲 (小有名氣)
|
Analysis of therapeutic effect of domestic Risperidone on non-psychotic disorders resulting from cerebrovascular diseases Abstract: Purpose: to probe into therapeutic effect and security of domestic Risperidone on non-psychotic disorders resulting from cerebrovascular diseases. Approach: to randomly draw 30 cases with non-psychotic disorders resulting from cerebrovascular diseases, treat them with Risperidone and then assess clinical curative effects and undesirable reactions with BPRS, PANSS and TCSS at the end of the first, second, fourth and eighth week before and after treatment. Result: aggregate score of BPRS and PANSS and each symptom score are considerablely much lower than that before treatment with significant variation (P<0.01~0.05). The effective rate is 90% and developing rate is 63%. Common undesirable reactions are gain in weight and loss of sitting still. Conclusion: Risperidone is secure and effective with a few undesirable reactions and deserves promotion and application because of its economically affordable and applicable trait on the treatment of non-psychotic disorders resulting from cerebrovascular diseases. |

木蟲 (正式寫手)
|
efficacy of Risperidone on brain vascular diseases caused psychonosema Abstract Object: to evaluate the efficacy and safety of Risperidone on brain vascular diseases caused psychonosema. Method: A total of 30 patients with psychonosema was randomly selected to treat with Risperidone, and clinical efficacy and adverse effect was recorded using BPRS, PANSS, and TCSS before treatment and at the end of 1, 2, 4, 8 weeks after treatment. Results: BPRS scores, PANSS scores and symptom scores decreased significantly compared to that of pre-treatment (P<0.01~0.05). Effective percentage is 90% while the obvious effective rate is 63%. Common adverse effects include: Weight gain, akathisia. Conclusion: Risperidone’s effectiveness, safety and minor adverse effect makes itself worthy of clinical use. |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 生物學(xué)學(xué)碩,一志愿湖南大學(xué),初試成績338 +5 | YYYYYNNNNN 2026-03-26 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 調(diào)劑310 +6 | 溫柔的晚安 2026-03-25 | 7/350 |
|
|
[考研] 085600,材料與化工321分求調(diào)劑 +9 | 大饞小子 2026-03-28 | 9/450 |
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-03-27 | 6/300 |
|
|
[考研] 材料求調(diào)劑一志愿哈工大324 +7 | 閆旭東 2026-03-28 | 9/450 |
|
|
[考研]
|
孅華 2026-03-22 | 17/850 |
|
|
[考研] 328求調(diào)劑 +7 | 嗯滴的基本都 2026-03-27 | 7/350 |
|
|
[考研] 305求調(diào)劑 +5 | 哇盧卡庫 2026-03-26 | 5/250 |
|
|
[考研] 322求調(diào)劑 +4 | 我真的很想學(xué)習(xí) 2026-03-23 | 4/200 |
|
|
[考研] 312求調(diào)劑 +9 | 上岸吧ZJY 2026-03-22 | 13/650 |
|
|
[考研] 324求調(diào)劑 +5 | hanamiko 2026-03-26 | 5/250 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-26 | 6/300 |
|
|
[考研] 085601求調(diào)劑總分293英一數(shù)二 +4 | 鋼鐵大炮 2026-03-24 | 4/200 |
|
|
[考研] 化學(xué)調(diào)劑一志愿上海交通大學(xué)336分-本科上海211 +4 | 小魚愛有機 2026-03-25 | 4/200 |
|
|
[考研] 332求調(diào)劑 +6 | 032500 2026-03-25 | 6/300 |
|
|
[考研] 材料專碩找調(diào)劑 +5 | 哈哈哈吼吼吼哈 2026-03-23 | 5/250 |
|
|
[考研] 384求調(diào)劑 +3 | 子系博 2026-03-22 | 6/300 |
|
|
[考研] 269求調(diào)劑 +4 | 我想讀研11 2026-03-23 | 4/200 |
|
|
[考研] 求調(diào)劑院校信息 +6 | CX 330 2026-03-21 | 6/300 |
|